HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The role of omalizumab or rhuMAB-E25 in the treatment of allergic rhinitis.

AuthorsD K C Lee
JournalThe European respiratory journal (Eur Respir J) Vol. 24 Issue 2 Pg. 330; author reply 330-1 (Aug 2004) ISSN: 0903-1936 [Print] England
PMID15332407 (Publication Type: Comment, Comparative Study, Letter)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • rhuMAb-E25
  • Omalizumab
Topics
  • Antibodies, Anti-Idiotypic
  • Antibodies, Monoclonal (administration & dosage)
  • Antibodies, Monoclonal, Humanized
  • Cohort Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Omalizumab
  • Rhinitis, Allergic, Seasonal (diagnosis, drug therapy)
  • Risk Assessment
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: